Beijing, China (PRWEB) May 11, 2013

Puhua International Hospitals (PIHs)-Temple of Heaven (http://www.puhuahospital.com), (http://www.puhuachina.com) has been a leading international neuroscience and biotechnology center in Beijing, China, for the past 20 years. During that time, Puhua International has achieved a dominant presence in Beijing, China, in applied biotechnology, cellular biotherapy, neurology, neurosurgery, medicine, cancer, traditional Chinese medicine (TCM) and surgery.

Puhua International is the only international hospital in Beijing to routinely evaluate, treat and admit a wide range of international patients. In fact, Puhua International was one of the first of what are now known as medical tourism facilities in Asia, and the level of expertise and care for all international patients is currently unrivaled. Patients repeatedly report in quality-control surveys that the International Service Department at Puhua International is unrivaled for quality and outstanding level of no-problems service. Patients come to this hospital with diagnoses ranging from metabolic, genetic and genetic disorders to central nervous system (brain and spinal cord) injury and trauma; glioma; seizure disorders; cerebral palsy; Parkinson's disease and a wide range of neuropathic and myopathic disorders. PIH also has vigorous programs of integrative oncology and diabetes.

Over the past decade Puhua International Hospitals-Temple of Heaven has made huge strides forward in applied cellular biotechnology (stem cell therapy, or SCT). Thus, in addition to its high level of diagnostic and therapeutic expertise, PIH has become a world leader in applied biotechnology, cellular science and applied stem cell technology. It is in these areas of applied clinical biotechnology that remarkable progress is being made at PIH in the areas of: spinal cord repair; post-traumatic brain injury; cerebral palsy; Parkinsons disease; cerebral-vascular and cardio-vascular disease, and diabetes. Other conditions managed at PIH include the management of difficult tumors and cancers, metabolic diseases and genetic disorders. By utilizing cellular/regenerative medicine and biotechnology at the time of surgical repair for spinal cord and brain injury, the neurosurgeons and clinical scientists at PIH are today redefining what is possible in recovery from neurological injury and disease.

Whereas traditional SCT utilizes donor cell-lines (for example, mesenchymal stem cells derived from donor placental cord blood), newer pathways using autologous stem cells (meaning stem cell lines derived from the patients own cells) are now also being successfully employed. Autologous stem cellular therapy is extremely safe and cost-effective for younger (under 40 years of age) patients with diagnoses such as: cerebral palsy, anoxic encephalopathy, autism, diabetes and many other problems.

Puhua International Hospitals-Temple of Heaven, Beijing (http://www.puhuahospital.com) (http://www.puhuachina.com) is thus a Center of Excellence in neurology and neurosurgery as well as a leader on the new frontier of applied stem cell science and biotechnology.

James T. Quinlan, MD, is an American physician, trained at the University of Iowa, with a life-long interest and commitment to the subject of wellness, regenerative medicine and anti-aging. He is heading the international initiative at Puhua International Hospitals (PIH)-Temple of Heaven. The goal is to apply what has been learned in the past decade of applied stem cell science to the important and fascinating frontiers of anti-aging/regenerative medicine, diabetes, heart failure and cancer as well as the range of neurologic, metabolic and genetic diseases.

It is toward the goal of expanding its world-wide referral base that Puhua International Hospitals (PIHs)-Temple of Heaven announces its request that serious and suitable candidates who are interested in serving as international referring agents to PIHs submit their Bio and/or CV to info(at)puhuachina(dot)com for evaluation and consideration. A pre-requisite to become a Puhua International Partner is a Bachelors Degree (or higher) and experience in a health-related field. Special consideration will be given to those candidates who possess medical backgrounds and/or experience. Valued attributes include a high level of inter-personal skills, facility with marketing concepts/experience and polished communication skills.

The Puhua International Partnership seeks greater presence in Africa, the Americas, Asia, Europe, India, South East Asia and the U.K. All training and orientation for these positions will be undertaken and underwritten by Puhua International Hospitals (PIH)-Temple of Heaven. Individuals who are already positioned to understand stem cell science, and who are also in a position to reach out through their local and regional media to patients most likely to benefit from advanced cellular therapy are encouraged to contact us at info(at)puhuachina(dot)com.

After many treating many thousands of patients with mesenchymal stem cells, we know that this technique is safe and generally effective, and the stem cells themselves are the stars in this process. Their extremely low antigenicity coupled with their predilection to go to where they are needed, blend in with the hosts own (and older) stem cells and then go on to differentiate in harmony with these older cells makes the technical aspects of this process very straight-forward. Still, not every question has been answered. Thus, while offering an anti aging and many other stem cell therapies, Puhua International is also coupling these treatments to prospective clinical studies in the search to expand medical knowledge.

Continued here:
Puhua International Hospitals (PIHs): Soliciting Agents for World-wide Referral Network